Results 101 to 110 of about 323 (141)

Predicting opioid consumption after surgical discharge: a multinational derivation and validation study using a foundation model. [PDF]

NPJ Digit Med
Varghese C, Peters L, Gaborit L, Xu W, Kalyanasundaram K, Basam A, Park M, Wells C, McLean KA, Schamberg G, O'Grady G, Wright D, Martin J, Harrison E, Pockney P, TASMAN Collaborative.   +15 more
europepmc   +1 more source

Concordance between FVC and FEV₆ for identifying chronic airflow obstruction and spirometric restriction in the Burden of Obstructive Lung Disease (BOLD) study. [PDF]

BMJ Open Respir Res
Knox-Brown B, Potts J, Franssen FME, Nielsen R, Denguezli M, Rotevatn AØ, Juvekar SK, Cherkaski HH, Studnicka M, Sylvester KP, Mortimer K, Bateman ED, Janson C, Malinovschi A, Seemungal T, Koul P, Mannino D, Mahesh PA, Jogi R, Mejza F, Al Ghobain M, Paraguas SNM, Welte T, Wouters E, Gislason T, Harrabi I, Dias H, Obaseki DO, Kocabas A, Barbara C, Cardoso J, Agarwal D, Nafees AA, Rodrigues F, Garcia-Larsen V, Erhabor GE, Loh LC, Amaral AFS, BOLD collaborative research group.   +38 more
europepmc   +1 more source

Cutaneous leishmaniasis in Afghanistan. [PDF]

Trans R Soc Trop Med Hyg
Rahimi BA, Ghatee MA, Habib MN, Farooqi K, Ritmeijer K, Hussain HS, Beg MA, Taylor WR.   +7 more
europepmc   +1 more source

Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000-2023: a systematic analysis from the Global Burden of Disease Study 2023. [PDF]

Lancet Child Adolesc Health
GBD 2023 Child Growth Failure Collaborators.
europepmc   +1 more source

Exploring the potential of photodynamic therapy in overcoming multidrug resistance: mechanisms, synergies, and clinical advancements in infectious diseases. [PDF]

Front Cell Infect Microbiol
Tanu R, Chaudhary AA, Prakash G, Yasmeen N, Ali MAM, Raza N, Sharma PK, Kumar A, Yadav T, Kumar V.   +9 more
europepmc   +1 more source

The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. [PDF]

Lancet
GBD 2023 Cancer Collaborators.
europepmc   +1 more source

Algerian leishmaniasis history. [PDF]

J Parasit Dis
Zeroual F, Diouani MF, Messaoudi N, Bessou ABE, Boukhezna A, Zeroual Z, Zeroual S, Zeroual M, Simione EV.   +8 more
europepmc   +1 more source

Bronchodilator responsiveness and future chronic airflow obstruction: a multinational longitudinal study. [PDF]

EClinicalMedicine
Knox-Brown B, Algharbi F, Mulhern O, Potts J, Harrabi I, Janson C, Nielsen R, Agarwal D, Malinovschi A, Juvekar S, Denguezli M, Gíslason T, Ahmed R, Nafees A, Koul PA, Obaseki D, Anand MP, Loh LC, Dias HB, Rodrigues F, Mannino D, Elbiaze M, El Rhazi K, Mejza F, Devereux G, Franssen FME, El Sony A, Wouters E, Al Ghobain M, Mortimer K, Rashid A, Osman R, Studnicka M, Cardoso J, Burney P, Amaral AFS, BOLD Collaborative Research Group.   +36 more
europepmc   +1 more source

Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future. [PDF]

World J Emerg Surg
Sartelli M, Mossialos E, Coccolini F, Jammer I, Labricciosa FM, Barie P, Biffl WL, Memish ZA, Maeurer M, Kobinger GP, Ippolito G, Zumla A, Catena F, Global Consortium for Solidarity to Overcome Challenges, Restore Trustand Advance Science for a Sustainable Future.   +14 more
europepmc   +1 more source

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. [PDF]

Lancet
GBD 2023 Disease and Injury and Risk Factor Collaborators.
europepmc   +1 more source